Literature DB >> 27053933

Chemotherapy and Functional Medicine in a Patient With Metastatic Breast Cancer: A Case Report.

Elliot T Taxman1, Erin D Conlon1, Alex Speers1, Kristin L Dismuke1, Tonya S Heyman1, Thomas L Taxman1.   

Abstract

More than one-half of all cancer patients use some combination of conventional and complementary medicine, but exactly how this is done and what the outcomes include are poorly understood. This case study reports the successful treatment of metastatic invasive ductal breast carcinoma by 2 physician groups with treatments that combined conventional chemotherapy with nutritional support guided by nutritional and digestive laboratory testing. The goal of minimizing side effects and enhancing outcomes was achieved in this patient who did not receive radiation therapy and is almost 3 y posttreatment with no evidence of recurrence.

Entities:  

Year:  2016        PMID: 27053933      PMCID: PMC4818066     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  4 in total

1.  Online survey of patients with breast cancer on complementary and alternative medicine.

Authors:  Jutta Huebner; Karsten Muenstedt; Franz J Prott; Christoph Stoll; Oliver Micke; Jens Buentzel; Ralph Muecke; Bianca Senf
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

2.  Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Authors:  Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

3.  Complementary and alternative medicine use and benefit finding among cancer patients.

Authors:  Sheila N Garland; David Valentine; Krupali Desai; Susan Li; Corey Langer; Tracey Evans; Jun J Mao
Journal:  J Altern Complement Med       Date:  2013-06-18       Impact factor: 2.579

Review 4.  The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life.

Authors:  Anitra C Carr; Margreet C M Vissers; John S Cook
Journal:  Front Oncol       Date:  2014-10-16       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.